Resmed (RSMDF) EBITDA Margin (2009 - 2026)
Resmed (RSMDF) reported EBITDA Margin of 34.92% for Q1 2026, up 192.0% on a YoY basis from 11.96% in Q1 2025, and up 1.05% quarter-over-quarter from 34.56% in Q4 2025.
Resmed (RSMDF) EBITDA Margin (2009 - 2026) Analysis & Trends
Resmed has reported EBITDA Margin for 18 years, with the latest figure at 34.92% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 192.0% year-over-year to 34.92%; the trailing twelve-month figure through Mar 2026 stood at 34.18% (up 207.0% YoY), and the FY2025 full-year result was 34.92%, up 485.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 34.92%, up from 34.56% in the prior quarter.
- The five-year high for EBITDA Margin was 34.92% in Q1 2026, with the low at 23.66% in Q4 2023.
- Historically, EBITDA Margin has averaged 29.93% across 5 years, with a median of 31.17% in 2024.
- Annual changes were most pronounced in 2023 — EBITDA Margin slumped 345 bps — and 2024, when it soared 889 bps.
- Resmed's EBITDA Margin stood at 27.1% in 2022, then dropped by 13 bps to 23.66% in 2023, then soared by 38 bps to 32.54% in 2024, then advanced by 6 bps to 34.56% in 2025, then grew by 1 bps to 34.92% in 2026.
- The last three EBITDA Margin figures came in at 34.92% (Q1 2026), 34.56% (Q4 2025), and 33.43% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 28.86% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.97% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 1.63% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 34.92% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 20.96% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 4.04% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -9.90% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 13.65% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.44% |
| 10 | Resmed | - | - | 890.98 Mn | 34.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.92% |
| Dec 31, 2025 | 34.56% |
| Sep 30, 2025 | 33.43% |
| Jun 30, 2025 | 33.72% |
| Mar 31, 2025 | 33.00% |
| Dec 31, 2024 | 32.54% |
| Sep 30, 2024 | 31.63% |
| Jun 30, 2024 | 31.17% |
| Mar 31, 2024 | 31.29% |
| Dec 31, 2023 | 23.66% |
| Sep 30, 2023 | 26.22% |
| Jun 30, 2023 | 24.53% |
| Mar 31, 2023 | 26.92% |
| Dec 31, 2022 | 27.10% |
| Sep 30, 2022 | 29.02% |
| Jun 30, 2022 | 27.92% |
| Mar 31, 2022 | 27.10% |
| Dec 31, 2021 | 27.79% |
| Sep 30, 2021 | 28.97% |
| Jun 30, 2021 | 27.58% |